Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply
- PMID: 34614338
- DOI: 10.1056/NEJMc2112373
Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply
Comment on
-
Adjuvant Olaparib in BRCA-Mutated Breast Cancer.N Engl J Med. 2021 Oct 7;385(15):1439. doi: 10.1056/NEJMc2112373. N Engl J Med. 2021. PMID: 34614336 No abstract available.
-
Adjuvant Olaparib in BRCA-Mutated Breast Cancer.N Engl J Med. 2021 Oct 7;385(15):1439-1440. doi: 10.1056/NEJMc2112373. N Engl J Med. 2021. PMID: 34614337 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical